du-21220 has been researched along with ketoprofen in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Scarpellini, F; Scarpellini, L; Spina, V | 1 |
| Anfuso, S; Grignaffini, A; Lo Cane, F; Nardelli, GB; Ronzoni, E; Soncini, E | 1 |
1 trial(s) available for du-21220 and ketoprofen
| Article | Year |
|---|---|
Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor.
Topics: Adult; Case-Control Studies; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Italy; Ketoprofen; Obstetric Labor, Premature; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Ritodrine; Tocolytic Agents; Treatment Outcome; Uterine Contraction; Vasotocin | 2007 |
5 other study(ies) available for du-21220 and ketoprofen
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
[The pharmacological options for an immediate intervention in threatened premature labor].
Topics: Adolescent; Adult; Butylscopolammonium Bromide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ketoprofen; Obstetric Labor, Premature; Parity; Pregnancy; Pregnancy Trimester, Third; Ritodrine | 1993 |